Singapore, doctor was caught injecting saline
Officials in the United States have approved a new COVID-19 antibody medication for persons with major health issues or allergies who are unable to receive appropriate protection via immunisation.
The Food and Medication Administration authorised AstraZeneca’s drug combination emergency use on Wednesday.
Cancer patients, organ transplant recipients, and persons with severe vaccine allergies may benefit from the medicine. According to health professionals, around 2% to 3% of the US population falls into this category.
Other antibody medications are used to treat COVID-19 infection or to prevent infection following probable viral exposure. The new AstraZeneca medicine is meant to be used as a long-term preventative measure rather than a therapy.
Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…
Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…
Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…
In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…
Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…
In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…